uniQure's Series A Round

uniQure raised a round of funding on February 16, 2012. Investors include Forbion Capital Partners.

uniQure is delivering on the promise of gene therapy, single treatments with potentially curative results. The company has developed a modular platform to rapidly bring new disease modifying therapies…

Articles about uniQure's Series A Round: